Immunic Inc. (IMUX) PT Raised to $61 at BMO Capital, Following Drug Trial Results

Go back to Immunic Inc. (IMUX) PT Raised to $61 at BMO Capital, Following Drug Trial Results
(NASDAQ: IMUX) Delayed: 16.06 -0.52 (3.14%)
Previous Close $16.58    52 Week High
Open $16.60    52 Week Low
Day High $16.84    P/E N/A 
Day Low $15.86    EPS
Volume 79,672